The NACC Guidelines are authoritative international consensus-based practice guidelines to inform clinicians regarding the safe and effective practice of invasive neurostimulation. The NACC 2017 guidelines were divided into three major sections: bleeding risk, infection risk, and prevention of neurologic injury. NACC 2021 is currently convening and is in the process of updating the 2017 guidelines. This session will provide the latest updates on neuromodulation risk mitigation practices and strategies.
Upon completion of this educational activity, participants should be able to:
- Describe the NACC guideline process, provide an overview of NACC 2017 and plans for NACC 2021.
- Explain bleeding and anticoagulation risks and risk mitigation strategies associated with interventional neuromodulation procedures.
- Identify infection risks and risk factors and infection risk mitigation strategies associated with interventional neuromodulation procedures.
- Discuss the major factors that contribute to minimizing the risk of neurologic injury.
Tim J. Lamer, MD
NACC Guidelines: Overview and Update
Jay S. Grider, DO PhD MBA
NACC Guidelines: Coagulation Management
Susan M. Moeschler, MD
NACC Guidelines: Infection Management
Tim J. Lamer, MD
NACC Guidelines: Neurologic Injury Prevention and Mitigation
Leonardo Kapural, MD PhD
Faculty and Presentations subject to change.
- Research in Neuromodulation: Trials and Tribulations
- Outcomes and Access to Neuromodulation for Women and Underrepresented Minorities: A Call to Action
- Engineering Principles of DBS and SCS in Clinical Practice: Emerging Concepts
- Open- vs. Closed-Loop Neurostimulation and Enabling Biomarkers
- American Academy of Pain Medicine (AAPM) Session: Integrating Neuromodulation Into Multimodal Pain Care